
Teleflex (TFX) Stock Forecast & Price Target
Teleflex (TFX) Analyst Ratings
Bulls say
Teleflex is expected to experience strong organic revenue growth, margin expansion, and potential accretive acquisitions in the coming years, leading to a positive outlook for its stock. The recent divestitures of non-core businesses and debt reduction also suggest the company is taking steps to optimize its operations and improve its financials. With a solid portfolio and a plan to spin-off or sell certain business lines, Teleflex has the potential for significant upside if all goes according to plan, but there are risks and uncertainties that could impact its performance. Overall, TFX is positioned for long-term success and has the potential to achieve mid-single digit organic growth and increased earnings power.
Bears say
Teleflex is a company facing challenges in its Interventional cardiology and UroLift businesses, which are expected to continue to impact its overall revenue and earnings growth significantly in the next few years. The recent divestitures by the company will also result in lower revenue and earnings expectations. However, potential upside risks include a faster-than-expected recovery in its UroLift business and successful execution of its cost reduction efforts.
This aggregate rating is based on analysts' research of Teleflex and is not a guaranteed prediction by Public.com or investment advice.
Teleflex (TFX) Analyst Forecast & Price Prediction
Start investing in Teleflex (TFX)
Order type
Buy in
Order amount
Est. shares
0 shares